Mollet del Valles, Spain

David Enrique Miguel Centeno

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2013-2014

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: David Enrique Miguel Centeno: Innovator in Pharmaceutical Compounds

Introduction

David Enrique Miguel Centeno is a notable inventor based in Mollet del Valles, Spain. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds aimed at treating and preventing various diseases and disorders. With a total of 3 patents to his name, Centeno's work is paving the way for new therapeutic options.

Latest Patents

Centeno's latest patents focus on innovative compounds that have the potential to modulate biological activity. One of his inventions relates to N-substituted-N-phenylethylsulfonamides, which are useful for biological and pharmacological screening. This invention aims to contribute to the exploration and identification of new lead molecules. Another patent involves N-(2-oxo-1-phenylpiperidin-3-yl)sulfonamides, which also serve a similar purpose in the search for effective treatments.

Career Highlights

Throughout his career, Centeno has worked with esteemed organizations such as Institut Universitari de Ciència i Tecnologia. His experience in these institutions has allowed him to refine his research skills and contribute to significant advancements in pharmaceutical science.

Collaborations

Centeno has collaborated with notable colleagues, including Josep Castells Boliart and Marta Pascual Gilabert. These partnerships have enhanced his research efforts and broadened the impact of his inventions.

Conclusion

David Enrique Miguel Centeno is a prominent figure in the field of pharmaceutical innovation. His dedication to developing novel compounds is making a meaningful difference in the quest for effective treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…